ACBD5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.419200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.341200E-01
Normal-vs-Stage2
8.101000E-01
Normal-vs-Stage3
7.026400E-01
Normal-vs-Stage4
4.411000E-01
Stage1-vs-Stage2
2.721200E-01
Stage1-vs-Stage3
3.375800E-01
Stage1-vs-Stage4
9.761000E-01
Stage2-vs-Stage3
3.734600E-01
Stage2-vs-Stage4
3.854000E-01
Stage3-vs-Stage4
3.073000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.772800E-01
Normal-vs-AfricanAmerican
3.063000E-01
Normal-vs-Asian
9.811600E-01
Caucasian-vs-AfricanAmerican
1.206030E-01
Caucasian-vs-Asian
7.413600E-01
AfricanAmerican-vs-Asian
1.195970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.991400E-01
Normal-vs-Female
8.895400E-01
Male-vs-Female
7.702000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.977800E-01
Normal-vs-Age(41-60Yrs)
6.638800E-01
Normal-vs-Age(61-80Yrs)
9.271400E-01
Normal-vs-Age(81-100Yrs)
9.685000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.272600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.074200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.116400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.271200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.998600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.407800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.330400E-01
Normal-vs-Daily Drinker
8.988000E-01
Normal-vs-Weekly Drinker
8.852400E-01
Normal-vs-Occasional Drinker
7.751400E-01
Normal-vs-Social Drinker
6.054800E-01
Non Drinker-vs-Daily Drinker
8.614600E-01
Non Drinker-vs-Weekly Drinker
6.457200E-01
Non Drinker-vs-Occasional Drinker
7.028400E-01
Non Drinker-vs-Social Drinker
2.991600E-01
Daily Drinker-vs-Weekly Drinker
6.371400E-01
Daily Drinker-vs-Occasional Drinker
8.965200E-01
Daily Drinker-vs-Social Drinker
3.206400E-01
Weekly Drinker-vs-Occasional Drinker
4.822200E-01
Weekly Drinker-vs-Social Drinker
7.134600E-01
Occasional Drinker-vs-Social Drinker
1.681830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.129900E-02
Normal-vs-Grade 2
1.074350E-02
Normal-vs-Grade 3
3.295800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.432200E-02
Grade 1-vs-Grade 3
1.924580E-01
Grade 1-vs-Grade 4
3.129900E-02
Grade 2-vs-Grade 3
9.354000E-01
Grade 2-vs-Grade 4
1.074350E-02
Grade 3-vs-Grade 4
3.295800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.222400E-01
Normal-vs-NonDiabetic
9.736800E-01
Diabetic-vs-NonDiabetic
6.807000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.663000E-01
Normal-vs-NoPancreatitis
9.665800E-01
Pancreatitis-vs-NoPancreatitis
9.848800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.760600E-01
Normal-vs-N1
8.456200E-01
N0-vs-N1
7.754800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.651000E-01
Normal-vs-TP53-NonMutant
7.569400E-01
TP53-Mutant-vs-TP53-NonMutant
1.518990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
